Adiuretin

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Adiuretin

The following section defines the essential nature, composition, and general pharmacological classification of the medicine Adiuretin (Desmopressin), highlighting key aspects of its formulation.

Property Description
Active Ingredient Desmopressin acetate (or Desmopressin)
Form Solution for nasal administration, Tablets, Solution for injection
Pharmacological Class Antidiuretic hormone analogue (Synthetic Vasopressin Analogue)
Common Purpose Managing fluid balance and reducing urine volume
Origin Synthetic peptide derivative

Defining Adiuretin: Active Ingredient and Pharmacological Class

Adiuretin is a pharmaceutical preparation containing the Desmopressin (Desmopressin acetate) as its single active ingredient. This medicine is formally classified as a Vasopressin analogue and an Antidiuretic agent, functioning as a highly selective V2 receptor agonist. Desmopressin is clinically recognized for its efficacy in controlling symptoms related to impaired water regulation.

Is Desmopressin a Natural Hormone or a Synthetic Peptide?

Desmopressin is strictly a synthetic peptide derivative and is not a natural substance extracted from the body. It was chemically engineered to amplify its antidiuretic potency while minimizing the systemic effects on blood pressure that the natural hormone exhibits. This specialized structural design differentiates it from natural vasopressin. This single-ingredient compound is formulated into several dosage forms, including the specialized aqueous solution for intranasal administration (nasal drops) and oral tablets.

What is the General Purpose of an Antidiuretic Analogue?

The general purpose of an Antidiuretic analogue like Desmopressin is to restore and maintain the body's fluid homeostasis by concentrating urine. The medicine works by promoting the reabsorption of water from the renal collecting ducts back into the bloodstream. This key physiological action directly results in a substantial reduction in the volume of urine produced. This capability is typically utilized for conditions requiring management of excessive water loss, where the goal is to control frequent and heavy urination.

Regulatory References

  1. Desmopressin (1-deamino-8-D-arginine vasopressin)
  2. Desmopressin as a synthetic peptide
  3. NIH: Desmopressin Drug Information

What side effects are possible with Adiuretin?

Possible Side Effects and Safety Information for Adiuretin (Desmopressin)

Adiuretin’s safety profile, as documented in official regulatory sources, is primarily defined by the risk of electrolyte imbalance and the frequency of common adverse reactions.

Serious Adverse Reactions

The most critical and officially documented serious adverse reaction is severe hyponatremia (low blood sodium). This condition can lead to water intoxication, and in rare cases, to seizures or coma. The regulatory profile emphasizes that this risk necessitates mandatory fluid restriction during therapy and close, required monitoring of serum sodium levels, especially during the first week of initiation or dose change. Rare thrombotic events and cases of severe hypersensitivity have also been documented.

Frequency-Classified Adverse Reactions

The table below outlines common adverse reactions categorized by frequency, based on clinical data:

Frequency Category Examples of Adverse Reactions (by System-Organ-Class)
Very Common Headache
Common Dizziness, Nausea, Dry mouth, Nasal congestion (with nasal forms)
Rare/Not Known Seizures, Thrombotic events, Anaphylaxis, Vomiting, Confusion

Safety Restrictions and Considerations

Official documents outline specific limitations for use:

  • Fluid Restriction: Strictly required to prevent hyponatremia and is a core safety constraint.
  • Kidney Function: Adiuretin is generally contraindicated in patients with moderate to severe renal impairment (GFR <50 mL/min) due to the increased risk of accumulation and hyponatremia.
  • Older Adults: Use in patients over 65 carries an elevated risk of severe hyponatremia, requiring extra caution and stringent monitoring. The medicine is contraindicated for nocturia in some elderly patients.

Overdose and Emergency Response

Overdose and when to seek help — Official Regulatory Information

Overdose involving Adiuretin (Desmopressin) is defined in regulatory documents by the clinical consequences of excessive antidiuretic effect, primarily leading to water intoxication and Hyponatremia (decreased serum sodium concentration).

The officially documented manifestations of overdose include a cluster of symptoms such as headache, nausea/vomiting, restlessness, confusion, lethargy, and abnormal signs like sudden weight gain and muscle spasms. Severe or life-threatening outcomes resulting from extreme hyponatremia are documented to include seizure, coma, and respiratory arrest. These severe manifestations establish the need for urgent medical intervention.

Emergency Actions and Management

Regulatory instructions mandate that individuals must seek immediate medical attention and contact the Poison Help line for any suspected overdose. Emergency services (911) must be called immediately if the affected person collapses, experiences a seizure, has trouble breathing, or cannot be awakened.

Management procedures officially described include the mandatory discontinuation of Desmopressin and the institution of rigorous fluid restriction. No specific antidote is known for this overdose. Treatment is symptomatic and supportive, requiring the monitoring of serum sodium concentrations. Regulatory labeling notes that pediatric and geriatric patients are identified as having a greater risk for severe hyponatremia during overdose.

Therapeutic Uses of Adiuretin

What Adiuretin Treats: Main Uses and Benefits

Adiuretin is commonly used to help with symptomatic management across distinct clinical domains, including situations involving systemic imbalance and specific coagulation deficits. Its core uses include treating Central Diabetes Insipidus and supporting hemostasis in certain bleeding disorders.

This medicine is applied in conditions presenting with systemic or localized discomfort, primarily addressing the pronounced symptoms of polyuria (excessive urination) and polydipsia (intense thirst) associated with Central Diabetes Insipidus. It is relevant for easing symptoms that relate to fluid imbalance, and may help reduce urine volume. This contributes to easing the overall symptom load related to constant thirst and frequent voiding.

It is also applied to manage symptom clusters where manifestations are driven by an excessive production of urine during sleep, such as Primary Nocturnal Enuresis in children and nocturia in adults. In a separate domain, this medicine is commonly used to help with symptomatic support for patients with specific mild coagulation deficiencies.


Quick Fact: Relief for Excessive Urination and Thirst Adiuretin is used for managing symptoms that create noticeable physiological strain, such as polyuria and the resulting polydipsia. The medication contributes to improved comfort during periods of heightened symptoms by addressing night-time voiding.

Eligibility and Restrictions for Use

Who Can and Cannot Use Adiuretin (Vasopressin)

The official eligibility for Adiuretin is strictly defined by regulatory documents, focusing on absolute prohibitions and restrictions based on specific patient populations or conditions.


Who Must Not Use Adiuretin (Contraindications)

Classification Population Status
Absolute Contraindication Patients with known hypersensitivity or allergy to 8-L-arginine vasopressin (the active ingredient). Prohibited
Absolute Contraindication Patients with known hypersensitivity to chlorobutanol (a preservative in certain formulations). Prohibited

Eligibility Limitations and Restrictions

Population Group Regulatory Status
Pediatric Patients Safety and effectiveness have not been established for the indicated use (vasodilatory shock).
Pregnant Patients Use is restricted due to the potential to induce tonic uterine contractions.
Cardiac Impairment Requires caution; official labeling warns of the potential to worsen cardiac output.

Use in older adults is generally allowed, but dose selection must be cautious due to the higher likelihood of reduced organ function. The primary eligible population for the indicated use is adults.

What should I know about interactions with other medicines?

Interactions with Other Medicines and Products

The interaction profile of Adiuretin (desmopressin) is primarily structured around the potential for pharmacodynamic interactions that increase the risk of low sodium levels (hyponatremia) or water intoxication.

Contraindicated Combinations and Agents

Certain combinations are officially contraindicated due to a significantly elevated risk of severe hyponatremia and fluid imbalance:

  • Loop Diuretics: Prohibited due to synergistic effects on fluid and electrolyte balance.
  • Systemic or Inhaled Glucocorticoids: Prohibited due to their association with fluid/electrolyte disturbances.

Other Clinically Significant Interactions

Many common medications require caution as they can additively increase the risk of hyponatremia. These include agents known to cause the Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) or otherwise affect water excretion:

  • Nonsteroidal Anti-inflammatory Drugs (NSAIDs): Including indomethacin.
  • Antidepressants: Including Selective Serotonin Reuptake Inhibitors (SSRIs) and Tricyclic Antidepressants (TCAs).
  • Other Agents: Such as Carbamazepine, Chlorpropamide, and Chlorpromazine.

Procedural and Lifestyle Constraints

The risk of interaction is tied to fluid management. Excessive fluid intake is a critical factor that must be strictly controlled, necessitating the restriction of fluid consumption for one hour before and eight hours after administration. Alcohol and caffeine intake may also be advised against, especially concerning nocturnal administration. Furthermore, the use of Adiuretin is contraindicated in patients with moderate to severe renal impairment (creatinine clearance < 50 mL/min) due to altered drug clearance.

Mechanism of Action

Selective Targeting of Renal Water Transport (V2 R)

Adiuretin works primarily as a highly selective agonist at the Vasopressin V2 Receptor on the principal cells of the renal collecting ducts. This molecular interaction triggers an intracellular cascade, increasing cAMP and promoting the rapid insertion of Aquaporin-2 (AQP-2) water channels into the apical membrane. This targeted action makes the renal tubules highly permeable to water, leading to the passive reabsorption of water back into the plasma, which results in a reduction of the final filtrate volume and an increase in urine osmolality.


Dual Action: Endothelial Activation and Minimal Vasopressor Activity

A secondary effect arises from V2 R activation on vascular endothelial cells, which causes a transient release of von Willebrand factor (VWF) and Coagulation Factor VIII from storage granules, contributing to a transient elevation in plasma levels of factors critical for primary hemostasis. Critically, the drug is structurally designed to maintain high antidiuretic-to-pressor selectivity, with minimal affinity for the V1a receptors responsible for blood vessel constriction. The mechanism is therefore not accompanied by significant systemic V1a receptor-mediated vasoconstriction.


Mechanistic Constraints

The drug's activity is constrained by the integrity of the V2 receptor and its downstream signaling, which defines a constraint on the pathway's function in biological conditions where the renal V2 receptors or related channels are defective. Furthermore, the hemostatic effect is subject to tachyphylaxis upon repeated high-dose administration, as the endothelial stores of VWF and Factor VIII require time for replenishment, imposing a temporary constraint on the exocytotic process.

Dosage and Administration Information

Official Administration Routes and Schedules

Adiuretin (Desmopressin) is administered through several officially approved routes, including oral tablets, intranasal spray/drops, sublingual wafers, and intravenous (IV) or subcutaneous (SC) injection.

Dosage is individualized and adjusted based on the patient's objective response. For oral use, the starting dose for Central Diabetes Insipidus (CDI) is typically 0.05 mg twice daily, while for Primary Nocturnal Enuresis (PNE) in patients over 6 years of age, the dose is initiated at 0.2 mg once daily at bedtime. The maximum labeled oral dose for PNE is 0.6 mg daily.

Key Procedural Requirements

Fluid Restriction: A mandatory requirement across all antidiuretic uses is the limitation of fluid intake from 1 hour before administration until at least 8 hours after the dose is taken. This restriction is crucial for the proper utilization of the medicine.

Administration Specifics:

  • Intravenous (IV) administration for coagulation purposes requires the dose to be diluted in sterile saline and infused slowly over a 15-to-30-minute period.
  • Intranasal spray pumps must be primed with a set number of initial actuations before the first use.
  • Dosing Frequency is based on the condition; CDI often requires divided doses daily to manage the diurnal water turnover, whereas PNE requires a single nightly dose.
  • Age and Renal Function: The drug is contraindicated in patients with moderate to severe renal impairment (CrCl below 50 mL/min). Older adults (ge 65 years) require fluid intake to be adjusted downward.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Adiuretin

Evidence for Fluid Balance Management: Central Diabetes Insipidus

Research examined Adiuretin in studies involving Central Diabetes Insipidus (CDI), a condition studied in research exploring temporary physiological imbalance. Studies monitored populations including adults and children (typically ge 4 years old) and focused on outcomes related to systemic imbalance, such as excessive urine output and thirst. Researchers monitored patterns related to urine volume and changes in urine concentration (osmolality) that were recorded in the study populations. Evidence for the full range of parameters examined in the research for this condition remains limited. Data for very young children (under age 4 years) for this condition remain insufficient.

Evidence for Managing Excessive Nighttime Urination (Nocturia and Enuresis)

Adiuretin was studied for conditions involving the production of excessive urine during sleep, such as Primary Nocturnal Enuresis (PNE) in children and Nocturia in adults.

Studies monitored children with PNE, examining outcomes such as the frequency of nocturnal wetting events. Research describes protocols that included close monitoring of physiological parameters in the study settings.

Randomized Controlled Trials (RCTs) examined Nocturia in adults and older adults (ge 65 years). Studies measured the number of times participants woke up to void. Research documented specific protocol modifications related to the observed increased association with hyponatremia in the older adult cohort. Researchers observed that the magnitude of the measured change was limited in some studies.

Evidence for Coagulation Support in Mild Bleeding Disorders

Adiuretin was evaluated in studies for patients with specific mild coagulation deficiencies. Studies monitored plasma levels for clotting factors like Factor VIII (FVIII). Findings were mixed when research examined the correlation between factor level changes and the reduction of clinically significant bleeding episodes. The follow-up durations were limited in many trials, and evidence for the full range of long-term outcomes remains limited. Study results reflect the specific conditions under which they were conducted and do not determine whether an individual will respond similarly.

Key Studies & References

  1. Desmopressin: Pharmacology and Clinical Use
  2. Efficacy and safety of desmopressin for treating primary nocturnal enuresis: A systematic review and meta-analysis
  3. The role of desmopressin in hemostasis

Frequently Asked Questions (FAQ)

Common questions about Adiuretin (FAQ)

Q: Why do some people call Adiuretin 'water medicine'?

Adiuretin is a synthetic analogue of the antidiuretic hormone (ADH), which plays a major role in regulating the body’s water balance. This medication acts on the kidneys to promote the reabsorption of water, reducing urine output. This core function of managing fluid is why the drug is sometimes colloquially referred to as 'water medicine'.


Q: How quickly does Adiuretin start to work after I take it?

Official information regarding the oral tablets indicates that the therapeutic effect, or antidiuretic action, typically begins about one hour after taking the dose. The maximum desired effect is generally reached between 4 to 7 hours.


Q: Does Adiuretin have a long-term effect or only while I'm taking it?

The drug's primary action is temporary, as it is gradually broken down and eliminated by the body. The antidiuretic effect of a single dose usually lasts up to 8 to 12 hours, depending on the administration route and dosage. Therefore, the medication only has an effect while it remains active in the body.


Q: Does Adiuretin cause weight gain or loss?

Regulatory safety documents list unexplained weight gain as a documented adverse reaction. This can be related to the drug’s intended action of retaining water, and is sometimes seen in cases of water intoxication or overdose.


Q: What is the difference between Adiuretin and other similar drugs, generally speaking?

Adiuretin, which is desmopressin, is a chemically engineered version of the natural hormone vasopressin. Studies show it is structurally designed to have an enhanced antidiuretic potency while minimizing effects on blood pressure (pressor effects) compared to the natural hormone itself.


Q: Are there any common foods or drinks that interact with Adiuretin?

Official product information notes that excessive fluid intake around the time of dosing is a critical factor that official guidance states is required to be limited to prevent safety concerns. Regulatory labels also sometimes advise against the use of alcohol and caffeine with the medication, particularly around nocturnal dosing.


Q: Is Adiuretin safe for people who drive or operate machinery?

The risk of low sodium (hyponatremia) can cause symptoms such as dizziness, headache, and confusion. Because these reactions may impact judgment and alertness, official warnings advise patients to be aware of these potential effects before driving or operating machinery.


Q: What happens if I forget to take my Adiuretin?

According to regulatory patient information leaflets, if a dose is missed, it is generally advised to skip the missed dose and continue with the regular dosing schedule. Patient information leaflets specify that a double dose is not intended to be taken.


Q: Is Adiuretin a controlled substance?

No. Official drug classification schedules confirm that Desmopressin (Adiuretin) is not listed as a controlled substance in the United States or equivalent international drug classification schedules.


Q: Do studies show Adiuretin is effective for its main purpose?

Clinical trials have examined the use of Adiuretin for its indicated purposes. Studies consistently show that the drug results in a reduction in urinary output and an accompanying increase in urine concentration for conditions such as Central Diabetes Insipidus and excessive nighttime urination.


Q: Is Adiuretin considered a short-term or long-term medication?

Regulatory information states that Adiuretin is indicated as replacement therapy for the management of Central Diabetes Insipidus, a use that often requires chronic or long-term administration. For other uses, the length of treatment is assessed on a periodic basis.


Q: Can Adiuretin affect my sleep schedule?

While the drug is used to help manage excessive urination at night, official adverse event reports have documented some central nervous system effects. These can include somnolence (drowsiness) and insomnia (difficulty sleeping).


Q: What should I do if the side effects of Adiuretin feel too strong?

If you experience severe side effects or any signs of low sodium (hyponatremia), such as severe headache, confusion, vomiting, or seizures, immediate medical attention or discontinuation of the drug is stated in official warnings to be necessary.


Q: Is there a generic version of Adiuretin available?

Yes, regulatory drug registries confirm that products containing the active ingredient desmopressin acetate are available from multiple manufacturers. These are classified as generic equivalents to the reference listed drug.


Q: Can people with diabetes use Adiuretin?

Adiuretin is used to treat Central Diabetes Insipidus, which is a condition involving water regulation, and is distinct from the more common Diabetes Mellitus (sugar diabetes). No general contraindication for Diabetes Mellitus is typically listed, but its use is a subject where fluid balance is carefully monitored.


Q: Can breastfeeding women take Adiuretin?

Studies included in authoritative databases indicate that desmopressin is excreted into breast milk in negligible amounts. Its use, particularly via nasal spray, is generally considered acceptable, but official guidance states that sublingual forms are used with caution while nursing a newborn.


Q: Are there different strengths of Adiuretin, and what do they mean?

The medicine is manufactured in multiple strengths for various forms, such as 0.1 mg and 0.2 mg tablets. Official product information states that these different strengths are necessary to allow for dose individualization and adjustment based on a patient’s specific needs and objective response to the drug.


Q: Is it possible to become dependent on Adiuretin?

Adiuretin is not classified as a controlled substance by major regulatory authorities. This classification indicates that the drug does not carry a federally regulated potential for abuse or dependence.


Q: How long after stopping Adiuretin do the effects wear off?

Pharmacokinetic data shows that the mean terminal half-life of the oral tablets—the time it takes for half the drug to be eliminated from the body—is approximately 2 to 3.11 hours in patients with normal kidney function.


Q: Do I need to change my salt intake while taking Adiuretin?

The official product information states that fluid restriction is a mandatory constraint to prevent low sodium (hyponatremia). However, there is no general regulatory guidance that mandates specific changes to a patient's dietary salt intake.


Q: Does Adiuretin help with fluid retention?

The drug is an antidiuretic, meaning it helps the kidneys reabsorb water back into the bloodstream to decrease the volume of urine produced. It is not formally indicated or approved for treating generalized fluid retention (edema).


Q: Is Adiuretin only available by prescription?

Yes, Desmopressin (Adiuretin) is classified by regulatory bodies as a prescription-only medicine (POM) in most jurisdictions and must be obtained under the direction of a licensed healthcare provider.


Q: What are the most common reasons a doctor might stop prescribing Adiuretin?

Regulatory guidance requires the drug to be temporarily or permanently stopped if a patient develops severe hyponatremia. Official regulatory documents indicate that discontinuation is also necessary during serious concurrent illnesses that disrupt fluid balance, such as prolonged vomiting, diarrhea, or fever.


Q: Are there specific tests a doctor performs before prescribing Adiuretin?

Regulatory precautions describe the necessity of assessing the serum sodium concentration before starting or resuming treatment. The official documents specify that the concentration is to be within the normal range, and kidney function is also generally assessed.


Q: Are there any long-term safety concerns with Adiuretin that have been studied?

The primary long-term safety concern that requires continuous vigilance throughout therapy is the risk of severe hyponatremia (low blood sodium). Official warnings state that regular monitoring of serum sodium levels is necessary during prolonged use.

How should Adiuretin be stored and disposed of?

Official Storage and Disposal Guidelines

Storage requirements for Desmopressin (Adiuretin) vary significantly by product type, according to regulatory documents.

Product Form Mandatory Storage Condition
Injection / Refrigerated Nasal Solution Refrigerated between 2 C to 8 C (Avoid freezing).
Oral Tablets Store at a temperature not above 25 C.
Opened Noctiva Nasal Spray Store at 20 C to 25 C for up to 60 days.

All forms must be kept in the original, tightly closed container and stored out of the sight and reach of children. Tablets require protection from moisture and light. Some refrigerated nasal products are stable for only three weeks when removed for travel, and must be discarded thereafter. Furthermore, certain nasal sprays must be discarded after a specific number of doses or a defined period, regardless of remaining liquid. Do not dispose of unused or expired medicine in household garbage or flush down the toilet, as official rules require disposal according to local environmental regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Adiuretin found in:

A-Z Index: